<<I think this stock is a no brainer as far as the dry eye thing goes>>
All we need to see is what RESTASIS got in Dry Eye. They only got a 15% response rate, vs 5% of placebo. The response rate is very low...but I guess it was enough" statistically" over placebo to get FDA approval. It's a $700 million drug.....a $1 billion market.in U.S........and only 15% respond. And the RESTASIS patent expres in less than two years (for Allergan).....so AGN better be hunting for a replacement for RESTASIS!
When you see small human tests done where TB 4 is curing eye ulcers, where nothing worked before...in 66% of pts tested....those are the kind of figures that make one dream...a 22 cent stock???
don't give sno too much credit for finding this one...and this is the reason I am here and buying now...this was and still is a sigma tau find...and after following them for years one would know from their game plan that you have to give them time to pick some meat off the company bones( distribution rights, stock deals, etc) before jumping in...same thing with QCOR, SCLN, SNGX...but these guys are proven winners and it is only a matter of time til there stocks move and usually not until they seem down and out...I think we are ready now to go...trial, patents,revenue all getting in line...still think there has been some patent infringement out there, we will see...nice day...